Janney Montgomery Scott’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$683K Buy
33,841
+20,024
+145% +$404K ﹤0.01% 2171
2026
Q1
$271K Sell
13,817
-413
-3% -$10.1K ﹤0.01% 2454
2025
Q4
$381K Buy
14,230
+825
+6% +$21.2K ﹤0.01% 2389
2025
Q3
$357K Buy
+13,405
New +$346K ﹤0.01% 2381
2024
Q1
Sell
-10,368
Closed -$641K 2718
2023
Q4
$641K Buy
+10,368
New +$545K ﹤0.01% 1723
2020
Q3
Sell
-17,038
Closed -$383K 2061
2020
Q2
$383K Buy
+17,038
New +$312K ﹤0.01% 1494

Other funds holding AMPH

Janney Montgomery Scott's AMPH Position: Q2 2026 in Review

Janney Montgomery Scott increased its Amphastar Pharmaceuticals (AMPH) stake by 145% in Q2 2026, buying an estimated $404K and bringing the position to 33,841 shares worth $683K. The position accounts for ﹤0.01% of the portfolio, ranked #2171.

Janney Montgomery Scott first reported a position in AMPH in Q2 2020 and has held it in 6 quarters since. 211 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • Janney Montgomery Scott held 33,841 shares of Amphastar Pharmaceuticals worth $683K as of Q2 2026.
  • Janney Montgomery Scott bought 20,024 Amphastar Pharmaceuticals shares in Q2 2026, an estimated $404K.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q2 2026, its #2171 holding.
  • Janney Montgomery Scott first reported a position in Amphastar Pharmaceuticals in Q2 2020 and has held it in 6 quarters since.
  • 211 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on Janney Montgomery Scott's 13F filing for Q2 2026, filed 5 Aug 2026.